| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 2.41e-08 | 39 | 161 | 7 | GO:0008187 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 2.79e-07 | 34 | 161 | 6 | GO:0008266 | |
| GeneOntologyMolecularFunction | deaminase binding | 2.05e-06 | 4 | 161 | 3 | GO:1990827 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 3.27e-05 | 111 | 161 | 7 | GO:0003727 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 4.51e-05 | 25 | 161 | 4 | GO:0070034 | |
| GeneOntologyMolecularFunction | poly(C) RNA binding | 6.46e-05 | 2 | 161 | 2 | GO:0017130 | |
| GeneOntologyMolecularFunction | poly(A) binding | 8.26e-05 | 29 | 161 | 4 | GO:0008143 | |
| GeneOntologyMolecularFunction | NACHT domain binding | 1.93e-04 | 3 | 161 | 2 | GO:0032089 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 2.18e-04 | 15 | 161 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 2.19e-04 | 37 | 161 | 4 | GO:0070717 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.27e-04 | 151 | 161 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.97e-04 | 40 | 161 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | calcium ion binding | CACNA1B MASP1 CIB2 PNLIPRP1 SMOC2 DYSF LRP1B SVEP1 RYR2 SLC8A1 FAT2 CDH20 SLIT3 EFCAB7 ATP2A2 PLS3 | 3.75e-04 | 749 | 161 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 MYD88 HSP90B2P MYO1D KIF16B RECQL MSH5 NLRP3 CCT6A SHPRH CCT6B DNAH5 ATP2A2 ATP2A3 | 4.64e-04 | 614 | 161 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activator activity | 6.36e-04 | 5 | 161 | 2 | GO:0140608 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 9.19e-04 | 24 | 161 | 3 | GO:0140517 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | MYD88 HNRNPCL1 PABPC1 HNRNPAB HNRNPU HNRNPCL3 CSDE1 HNRNPCL2 | 4.01e-07 | 87 | 161 | 8 | GO:1902373 |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | MYD88 HNRNPCL1 PABPC1 HNRNPAB HNRNPU HNRNPCL3 CSDE1 HNRNPCL2 | 1.26e-06 | 101 | 161 | 8 | GO:1902369 |
| GeneOntologyBiologicalProcess | mRNA stabilization | 2.36e-06 | 77 | 161 | 7 | GO:0048255 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | MYD88 HNRNPCL1 PABPC1 HNRNPAB HNRNPU HNRNPCL3 CSDE1 HNRNPCL2 | 3.37e-06 | 115 | 161 | 8 | GO:1903312 |
| GeneOntologyBiologicalProcess | RNA stabilization | 5.79e-06 | 88 | 161 | 7 | GO:0043489 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 9.18e-06 | 6 | 161 | 3 | GO:0090367 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 1.60e-05 | 7 | 161 | 3 | GO:0090365 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomerase | 3.98e-05 | 25 | 161 | 4 | GO:0032211 | |
| GeneOntologyBiologicalProcess | mRNA modification | 4.68e-05 | 26 | 161 | 4 | GO:0016556 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 6.06e-05 | 2 | 161 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | positive regulation of macropinocytosis | 6.06e-05 | 2 | 161 | 2 | GO:1905303 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 6.33e-05 | 28 | 161 | 4 | GO:0010882 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 7.29e-05 | 29 | 161 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | CRD-mediated mRNA stabilization | 7.36e-05 | 11 | 161 | 3 | GO:0070934 | |
| GeneOntologyBiologicalProcess | macropinocytosis | 7.36e-05 | 11 | 161 | 3 | GO:0044351 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 9.55e-05 | 31 | 161 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 9.75e-05 | 12 | 161 | 3 | GO:1900152 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 1.05e-04 | 60 | 161 | 5 | GO:0032210 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | MYD88 HNRNPCL1 DYSF PABPC1 HNRNPAB HNRNPU HNRNPCL3 CSDE1 USP14 PPARGC1A SCFD1 HNRNPCL2 | 1.13e-04 | 418 | 161 | 12 | GO:0009895 |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 1.23e-04 | 33 | 161 | 4 | GO:1904357 | |
| GeneOntologyBiologicalProcess | regulation of macropinocytosis | 1.81e-04 | 3 | 161 | 2 | GO:1905301 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 2.05e-04 | 69 | 161 | 5 | GO:1904356 | |
| GeneOntologyBiologicalProcess | response to ATP | 2.63e-04 | 40 | 161 | 4 | GO:0033198 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic translation | 2.93e-04 | 17 | 161 | 3 | GO:2000767 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 3.18e-04 | 42 | 161 | 4 | GO:0032205 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 3.42e-04 | 77 | 161 | 5 | GO:0007004 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA biosynthetic process | 3.48e-04 | 43 | 161 | 4 | GO:2000279 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 3.81e-04 | 44 | 161 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | myeloid cell activation involved in immune response | 4.50e-04 | 125 | 161 | 6 | GO:0002275 | |
| GeneOntologyBiologicalProcess | NLRP3 inflammasome complex assembly | 4.52e-04 | 46 | 161 | 4 | GO:0044546 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 4.84e-04 | 83 | 161 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | FLII HNRNPCL1 PECAM1 DYSF HORMAD1 HNRNPU HNRNPCL3 PPARGC1A SCFD1 HNRNPCL2 SLC25A31 | 4.85e-04 | 421 | 161 | 11 | GO:0010639 |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 8.82e-06 | 6 | 161 | 3 | GO:1990826 | |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 3.78e-05 | 25 | 161 | 4 | GO:0005697 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 9.95e-05 | 96 | 161 | 6 | GO:0010494 | |
| GeneOntologyCellularComponent | dendrite | CACNA1B MYO1D HTR7 ASIC2 ACAD9 SARM1 APLP2 GRIK1 BCR PABPC1 HNRNPAB HNRNPU PPARGC1A SLC8A1 PTPRZ1 DLG4 C9orf72 SLC9A6 | 1.13e-04 | 858 | 161 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1B MYO1D HTR7 ASIC2 ACAD9 SARM1 APLP2 GRIK1 BCR PABPC1 HNRNPAB HNRNPU PPARGC1A SLC8A1 PTPRZ1 DLG4 C9orf72 SLC9A6 | 1.17e-04 | 860 | 161 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | PABPC4 PABPC1 HNRNPAB HNRNPU CSDE1 WTIP PABPC1L C9orf72 DYRK3 | 2.46e-04 | 269 | 161 | 9 | GO:0036464 |
| GeneOntologyCellularComponent | ribonucleoprotein granule | PABPC4 PABPC1 HNRNPAB HNRNPU CSDE1 WTIP PABPC1L C9orf72 DYRK3 | 3.96e-04 | 287 | 161 | 9 | GO:0035770 |
| GeneOntologyCellularComponent | sperm plasma membrane | 6.20e-04 | 22 | 161 | 3 | GO:0097524 | |
| GeneOntologyCellularComponent | mCRD-mediated mRNA stability complex | 8.67e-04 | 6 | 161 | 2 | GO:0106002 | |
| GeneOntologyCellularComponent | CRD-mediated mRNA stability complex | 8.67e-04 | 6 | 161 | 2 | GO:0070937 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 9.12e-04 | 56 | 161 | 4 | GO:0031234 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 9.28e-04 | 97 | 161 | 5 | GO:0071013 | |
| GeneOntologyCellularComponent | ruffle | 1.11e-03 | 206 | 161 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 1.26e-03 | 61 | 161 | 4 | GO:0030660 | |
| GeneOntologyCellularComponent | pronucleus | 1.28e-03 | 28 | 161 | 3 | GO:0045120 | |
| GeneOntologyCellularComponent | early endosome | HSPD1 CLTCL1 MYO1D KIF16B DYSF AP3M1 APPL2 AP1S2 APPL1 SLC9A6 VPS13B | 1.29e-03 | 481 | 161 | 11 | GO:0005769 |
| GeneOntologyCellularComponent | NLRP3 inflammasome complex | 1.60e-03 | 8 | 161 | 2 | GO:0072559 | |
| GeneOntologyCellularComponent | cell leading edge | MYO1D PECAM1 DYSF PABPC1 APPL2 PTPRZ1 APPL1 ADAM17 PLCG2 ARHGAP18 USH2A | 1.75e-03 | 500 | 161 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 1.90e-03 | 114 | 161 | 5 | GO:0005798 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 2.05e-03 | 9 | 161 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | neuron projection terminus | 2.23e-03 | 233 | 161 | 7 | GO:0044306 | |
| GeneOntologyCellularComponent | cation channel complex | 2.34e-03 | 235 | 161 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.44e-03 | 73 | 161 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1B MYO1D HTR7 ASIC2 ACAD9 SARM1 APLP2 GRIK1 BCR PABPC1 HNRNPAB HNRNPU PPARGC1A SLC8A1 PTPRZ1 DLG4 C9orf72 USH2A SLC9A6 | 2.93e-03 | 1228 | 161 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | neuron spine | 3.09e-03 | 247 | 161 | 7 | GO:0044309 | |
| GeneOntologyCellularComponent | pinosome | 3.10e-03 | 11 | 161 | 2 | GO:0044352 | |
| GeneOntologyCellularComponent | chaperonin-containing T-complex | 3.10e-03 | 11 | 161 | 2 | GO:0005832 | |
| GeneOntologyCellularComponent | macropinosome | 3.10e-03 | 11 | 161 | 2 | GO:0044354 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 3.10e-03 | 11 | 161 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 3.15e-03 | 185 | 161 | 6 | GO:0009898 | |
| Domain | PolyA | 6.09e-06 | 5 | 160 | 3 | SM00517 | |
| Domain | - | 6.09e-06 | 5 | 160 | 3 | 1.10.1900.10 | |
| Domain | PABP | 6.09e-06 | 5 | 160 | 3 | PF00658 | |
| Domain | PABP_1234 | 6.09e-06 | 5 | 160 | 3 | IPR006515 | |
| Domain | PABC | 6.09e-06 | 5 | 160 | 3 | PS51309 | |
| Domain | PABP_HYD | 6.09e-06 | 5 | 160 | 3 | IPR002004 | |
| Domain | hnRNP_C | 1.21e-05 | 6 | 160 | 3 | IPR017347 | |
| Domain | ConA-like_dom | 1.97e-05 | 219 | 160 | 10 | IPR013320 | |
| Domain | Chaprnin_Cpn60 | 4.99e-05 | 9 | 160 | 3 | IPR001844 | |
| Domain | Chap_CCT_zeta | 7.29e-05 | 2 | 160 | 2 | IPR012722 | |
| Domain | - | 1.67e-04 | 95 | 160 | 6 | 2.60.120.200 | |
| Domain | EF-hand-dom_pair | CACNA1B CIB2 LRRC74A SMOC2 RYR2 TBC1D8 SCN9A PLCG2 EFCAB7 PLS3 | 1.88e-04 | 287 | 160 | 10 | IPR011992 |
| Domain | GROEL-like_equatorial | 2.10e-04 | 14 | 160 | 3 | IPR027413 | |
| Domain | - | 2.10e-04 | 14 | 160 | 3 | 1.10.560.10 | |
| Domain | P-type_ATPase_IIA | 2.18e-04 | 3 | 160 | 2 | IPR005782 | |
| Domain | GroEL-like_apical_dom | 2.60e-04 | 15 | 160 | 3 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 2.60e-04 | 15 | 160 | 3 | IPR002423 | |
| Domain | Cpn60_TCP1 | 2.60e-04 | 15 | 160 | 3 | PF00118 | |
| Domain | - | 2.60e-04 | 15 | 160 | 3 | 3.50.7.10 | |
| Domain | LAM_G_DOMAIN | 3.05e-04 | 38 | 160 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 3.73e-04 | 40 | 160 | 4 | PF02210 | |
| Domain | Nucleotide-bd_a/b_plait | HNRNPCL1 PABPC4 PABPC1 HNRNPAB PPARGC1A MCM3AP HNRNPCL4 PABPC1L HNRNPCL2 | 3.92e-04 | 258 | 160 | 9 | IPR012677 |
| Domain | LamGL | 4.33e-04 | 4 | 160 | 2 | SM00560 | |
| Domain | LamG-like | 4.33e-04 | 4 | 160 | 2 | IPR006558 | |
| Domain | RRM_1 | HNRNPCL1 PABPC4 PABPC1 HNRNPAB PPARGC1A HNRNPCL4 PABPC1L HNRNPCL2 | 4.35e-04 | 208 | 160 | 8 | PF00076 |
| Domain | LamG | 5.39e-04 | 44 | 160 | 4 | SM00282 | |
| Domain | RRM | HNRNPCL1 PABPC4 PABPC1 HNRNPAB PPARGC1A HNRNPCL4 PABPC1L HNRNPCL2 | 5.75e-04 | 217 | 160 | 8 | SM00360 |
| Domain | Autophagy-rel_C | 7.17e-04 | 5 | 160 | 2 | IPR015412 | |
| Domain | ATG_C | 7.17e-04 | 5 | 160 | 2 | PF09333 | |
| Domain | RRM_dom | HNRNPCL1 PABPC4 PABPC1 HNRNPAB PPARGC1A HNRNPCL4 PABPC1L HNRNPCL2 | 7.72e-04 | 227 | 160 | 8 | IPR000504 |
| Domain | RRM | HNRNPCL1 PABPC4 PABPC1 HNRNPAB PPARGC1A HNRNPCL4 PABPC1L HNRNPCL2 | 8.41e-04 | 230 | 160 | 8 | PS50102 |
| Domain | RRM_1 | 9.63e-04 | 23 | 160 | 3 | SM00361 | |
| Domain | RRM_dom_euk | 9.63e-04 | 23 | 160 | 3 | IPR003954 | |
| Domain | Sushi | 1.02e-03 | 52 | 160 | 4 | PF00084 | |
| Domain | KRAB | ZNF671 ZNF486 ZNF584 ZNF175 ZNF180 ZNF254 ZNF585B ZNF182 ZNF37A ZNF253 | 1.06e-03 | 358 | 160 | 10 | PS50805 |
| Domain | KRAB | ZNF671 ZNF486 ZNF584 ZNF175 ZNF180 ZNF254 ZNF585B ZNF182 ZNF37A ZNF253 | 1.06e-03 | 358 | 160 | 10 | PF01352 |
| Domain | CCP | 1.18e-03 | 54 | 160 | 4 | SM00032 | |
| Domain | - | HNRNPCL1 PABPC4 PABPC1 HNRNPAB PPARGC1A HNRNPCL4 PABPC1L HNRNPCL2 | 1.23e-03 | 244 | 160 | 8 | 3.30.70.330 |
| Domain | KRAB | ZNF671 ZNF486 ZNF584 ZNF175 ZNF180 ZNF254 ZNF585B ZNF182 ZNF37A ZNF253 | 1.33e-03 | 369 | 160 | 10 | SM00349 |
| Domain | SUSHI | 1.35e-03 | 56 | 160 | 4 | PS50923 | |
| Domain | KRAB | ZNF671 ZNF486 ZNF584 ZNF175 ZNF180 ZNF254 ZNF585B ZNF182 ZNF37A ZNF253 | 1.35e-03 | 370 | 160 | 10 | IPR001909 |
| Domain | Sushi_SCR_CCP_dom | 1.44e-03 | 57 | 160 | 4 | IPR000436 | |
| Domain | Laminin_G | 1.54e-03 | 58 | 160 | 4 | IPR001791 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 6.45e-05 | 25 | 125 | 4 | MM15606 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.13e-04 | 54 | 125 | 5 | M27460 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.41e-04 | 12 | 125 | 3 | M27326 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.56e-04 | 130 | 125 | 7 | M27454 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.85e-04 | 178 | 125 | 8 | M2890 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.31e-04 | 14 | 125 | 3 | MM15052 | |
| Pubmed | Selective disruption of genes expressed in totipotent embryonal stem cells. | 7.10e-09 | 6 | 164 | 4 | 1317320 | |
| Pubmed | 1.97e-07 | 28 | 164 | 5 | 25332179 | ||
| Pubmed | Junctophilin-2 is necessary for T-tubule maturation during mouse heart development. | 2.29e-07 | 12 | 164 | 4 | 23715556 | |
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 4.10e-07 | 4 | 164 | 3 | 35729324 | |
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 36681355 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 4.10e-07 | 4 | 164 | 3 | 10805751 | |
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 23831410 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 FLII POLR2B RECQL PABPC1 HNRNPAB WDR59 ZBED5 HNRNPU CSDE1 USP14 CCT6A NSUN5 WDR75 MCM3AP MRPS23 CCT6B PLCG2 SCFD1 MGA ATP2A2 MED12 | 4.48e-07 | 1353 | 164 | 22 | 29467282 |
| Pubmed | HSPD1 CLTCL1 MYO1D ETF1 AP3M1 PABPC1 HNRNPU CSDE1 CCT6A ATP2A2 ATP2A3 PLS3 | 6.59e-07 | 411 | 164 | 12 | 36652389 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | FLII DPYD ACAD9 POLR2B ETF1 RECQL DYSF AP3M1 TRANK1 SCN9A SHPRH ATP2A3 MED12 | 7.66e-07 | 497 | 164 | 13 | 36774506 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 9.71e-07 | 38 | 164 | 5 | 30786075 | |
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 29846695 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 1.02e-06 | 5 | 164 | 3 | 25809670 | |
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 9128719 | ||
| Pubmed | HSPD1 FLII HSP90B2P HNRNPCL1 MYO1D PABPC4 ETF1 BCR AP3M1 PABPC1 HNRNPAB HNRNPU HNRNPCL3 CSDE1 CCT6A APPL2 PTPRZ1 DLG4 ATP2A2 PLS3 EPB41L1 HNRNPCL2 | 1.13e-06 | 1431 | 164 | 22 | 37142655 | |
| Pubmed | HSPD1 FLII CHAF1B MYO1D ACAD9 POLR2B PABPC4 BCR PABPC1 HNRNPAB HNRNPU HNRNPCL3 FANCD2 CSDE1 CCT6A WDR75 MRPS23 CCT6B SCFD1 ATP2A2 PLS3 | 1.42e-06 | 1335 | 164 | 21 | 29229926 | |
| Pubmed | HSPD1 PABPC4 ETF1 ATG2B THSD1 AP3M1 PABPC1 HNRNPU TBC1D8 CSDE1 CCT6A ATP2A2 PLS3 MED12 EPB41L1 | 1.48e-06 | 708 | 164 | 15 | 39231216 | |
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 26048669 | ||
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 15687492 | ||
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 18363099 | ||
| Pubmed | HSPD1 FLII MYO1D POLR2B PABPC4 PABPC1 HNRNPAB HNRNPU CSDE1 CCT6A MRPS23 PLS3 | 2.59e-06 | 469 | 164 | 12 | 37314180 | |
| Pubmed | Glucocorticoid receptor is required for foetal heart maturation. | 3.26e-06 | 22 | 164 | 4 | 23595884 | |
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 25846207 | ||
| Pubmed | HSPD1 FLII MYO1D PABPC4 PABPC1 HNRNPAB HNRNPU CSDE1 CCT6A PLS3 | 3.85e-06 | 327 | 164 | 10 | 31409639 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 4.38e-06 | 195 | 164 | 8 | 17110338 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 4.62e-06 | 139 | 164 | 7 | 16985003 | |
| Pubmed | 4.70e-06 | 24 | 164 | 4 | 22534482 | ||
| Pubmed | HSPD1 CIB2 HNRNPCL1 CLTCL1 MYO1D PABPC4 PABPC1 HNRNPAB RYR2 HNRNPU KRT73 HNRNPCL3 TRIM16 CCT6A WDR75 SCN9A PABPC1L ATP2A2 ATP2A3 HNRNPCL2 SLC25A31 | 4.71e-06 | 1442 | 164 | 21 | 35575683 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 5.67e-06 | 8 | 164 | 3 | 19033399 | |
| Pubmed | Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. | 6.57e-06 | 26 | 164 | 4 | 15890332 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 7.54e-06 | 210 | 164 | 8 | 26217791 | |
| Pubmed | 8.47e-06 | 9 | 164 | 3 | 10452948 | ||
| Pubmed | 8.47e-06 | 9 | 164 | 3 | 27909057 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | HSP90B2P ACAD9 PABPC4 BCR PABPC1 HNRNPAB HNRNPU ATP2A2 MED12 | 8.68e-06 | 283 | 164 | 9 | 28533407 |
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 1.19e-05 | 30 | 164 | 4 | 15782174 | |
| Pubmed | 1.31e-05 | 298 | 164 | 9 | 30737378 | ||
| Pubmed | HSPD1 POLR2B PABPC4 TOPBP1 BCR PABPC1 HNRNPAB HNRNPU CCT6A HNRNPCL2 | 1.78e-05 | 390 | 164 | 10 | 17643375 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 FLII RPP40 POLR2B PABPC4 ETF1 RECQL AP3M1 PABPC1 HNRNPAB HNRNPU FANCD2 TRIM16 CSDE1 USP14 CCT6A APPL2 APPL1 PLS3 EPB41L1 | 1.86e-05 | 1455 | 164 | 20 | 22863883 |
| Pubmed | Interaction between nucleosome assembly protein 1-like family members. | 2.20e-05 | 12 | 164 | 3 | 21333655 | |
| Pubmed | 2.20e-05 | 12 | 164 | 3 | 19095005 | ||
| Pubmed | The biogenesis of the coiled body during early mouse development. | 2.20e-05 | 12 | 164 | 3 | 7768196 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 22340213 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 26445298 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 31347915 | ||
| Pubmed | Distinct Roles for APPL1 and APPL2 in Regulating Toll-like Receptor 4 Signaling in Macrophages. | 2.21e-05 | 2 | 164 | 2 | 27219021 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 19650915 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 34587665 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 28185410 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 18263599 | ||
| Pubmed | ASIC2 subunits facilitate expression at the cell surface and confer regulation by PSD-95. | 2.21e-05 | 2 | 164 | 2 | 24699665 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 36514221 | ||
| Pubmed | Partial rescue of the Na+-Ca2+ exchanger (NCX1) knock-out mouse by transgenic expression of NCX1. | 2.21e-05 | 2 | 164 | 2 | 12754417 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 26812922 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 16424162 | ||
| Pubmed | Adaptor protein APPL1 coordinates HDAC3 to modulate brown adipose tissue thermogenesis in mice. | 2.21e-05 | 2 | 164 | 2 | 31390528 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 25270119 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 17675290 | ||
| Pubmed | Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. | 2.21e-05 | 2 | 164 | 2 | 20182451 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 32689633 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 22456474 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 27827420 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 23585683 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 22933787 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 22128899 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 21885870 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 31529732 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 36835594 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 21690334 | ||
| Pubmed | Association of CARD8 Activating Polymorphism With Bone Erosion in Cholesteatoma Patients. | 2.21e-05 | 2 | 164 | 2 | 32396255 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 37712526 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 24342062 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 23977033 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 23857504 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 20814572 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 30816317 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 24098386 | ||
| Pubmed | Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms. | 2.21e-05 | 2 | 164 | 2 | 21621776 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 19962989 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 27300007 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 24517500 | ||
| Pubmed | Shroom4 (Kiaa1202) is an actin-associated protein implicated in cytoskeletal organization. | 2.21e-05 | 2 | 164 | 2 | 17009331 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 20976179 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 31134059 | ||
| Pubmed | Integrative analyses of RNA-seq and ChIP-seq Reveal MITF as a Target Gene of TFPI-2 in MDA231 Cells. | 2.21e-05 | 2 | 164 | 2 | 36787085 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 29230505 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 18295663 | ||
| Pubmed | MITF is necessary for generation of prostaglandin D2 in mouse mast cells. | 2.21e-05 | 2 | 164 | 2 | 15375155 | |
| Pubmed | Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn's disease. | 2.21e-05 | 2 | 164 | 2 | 29408806 | |
| Pubmed | CLIC-2 modulates cardiac ryanodine receptor Ca2+ release channels. | 2.21e-05 | 2 | 164 | 2 | 15147738 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 32312889 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 20716843 | ||
| Pubmed | Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF. | 2.21e-05 | 2 | 164 | 2 | 16337607 | |
| Pubmed | 2.23e-05 | 35 | 164 | 4 | 23716698 | ||
| Pubmed | 2.23e-05 | 244 | 164 | 8 | 30349055 | ||
| Pubmed | 2.50e-05 | 36 | 164 | 4 | 17289661 | ||
| Pubmed | TFPI2 PECAM1 PABPC4 APLP2 SVEP1 RYR2 ZBED5 MCM3AP PAPPA PLCG2 ZNF83 MGA | 2.61e-05 | 591 | 164 | 12 | 15231748 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HSPD1 FLII MYO1D ACAD9 POLR2B SARM1 KIF16B ATG2B HNRNPAB FANCD2 HDAC3 CCT6A TIMM9 WDR75 MRPS23 OCIAD2 SCFD1 C9orf72 ATP2A2 VPS13B | 2.76e-05 | 1496 | 164 | 20 | 32877691 |
| Pubmed | 2.84e-05 | 13 | 164 | 3 | 32457985 | ||
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 2.96e-05 | 125 | 164 | 6 | 21654808 | |
| Pubmed | HSPD1 CACNA1B FLII HSP90B2P ATG2B BCR LRP1B AP3M1 HNRNPAB RYR2 HNRNPU CSDE1 CCT6A APPL1 DLG4 ATP2A2 EPB41L1 | 2.97e-05 | 1139 | 164 | 17 | 36417873 | |
| Interaction | TRIM28 interactions | MYD88 FLII CHAF1B ZNF486 ZNF584 POLR2B PABPC4 ZNF254 RECQL PABPC1 HNRNPAB NLRP3 HNRNPU ZNF585B FANCD2 CSDE1 HDAC3 USP14 CCT6A NSUN5 ZNF182 ZNF37A ZNF253 MRPS23 DZIP3 AP1S2 SCFD1 C9orf72 DNAH5 ATP2A3 PHF13 | 8.78e-07 | 1474 | 164 | 31 | int:TRIM28 |
| GeneFamily | Chaperonins | 1.35e-04 | 15 | 124 | 3 | 587 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.29e-04 | 57 | 124 | 4 | 1179 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MDGA2 LRP1B RYR2 PPARGC1A SLC8A1 TRANK1 SCN9A CSMD1 DNAH5 USH2A | 1.74e-09 | 184 | 164 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MDGA2 LRP1B RYR2 PPARGC1A SLC8A1 TRANK1 SCN9A CSMD1 DNAH5 USH2A | 1.74e-09 | 184 | 164 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MDGA2 LRP1B RYR2 PPARGC1A SLC8A1 TRANK1 SCN9A CSMD1 DNAH5 USH2A | 1.74e-09 | 184 | 164 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.00e-07 | 200 | 164 | 8 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.00e-07 | 200 | 164 | 8 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.00e-07 | 200 | 164 | 8 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.00e-07 | 200 | 164 | 8 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.00e-07 | 200 | 164 | 8 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.00e-07 | 200 | 164 | 8 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 2.59e-06 | 164 | 164 | 7 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-06 | 170 | 164 | 7 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.78e-06 | 180 | 164 | 7 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.93e-06 | 186 | 164 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.15e-06 | 187 | 164 | 7 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.36e-06 | 188 | 164 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 7.30e-06 | 192 | 164 | 7 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 7.81e-06 | 194 | 164 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-06 | 194 | 164 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-06 | 194 | 164 | 7 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | IPF-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 8.08e-06 | 195 | 164 | 7 | 50edda117b438b9c3616191884007466f6d974f0 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.08e-06 | 195 | 164 | 7 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 8.35e-06 | 196 | 164 | 7 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.63e-06 | 197 | 164 | 7 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.63e-06 | 197 | 164 | 7 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.63e-06 | 197 | 164 | 7 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.63e-06 | 197 | 164 | 7 | b11a5d909942a4299cbc0b27332b1a3f66f3bccd | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.53e-06 | 200 | 164 | 7 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.53e-06 | 200 | 164 | 7 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.53e-06 | 200 | 164 | 7 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 9.53e-06 | 200 | 164 | 7 | be83f442179ba4217d12f0458059586ff3130991 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.84e-05 | 148 | 164 | 6 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.98e-05 | 150 | 164 | 6 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.14e-05 | 152 | 164 | 6 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.66e-05 | 158 | 164 | 6 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.76e-05 | 159 | 164 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 160 | 164 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 160 | 164 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 3.39e-05 | 165 | 164 | 6 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.51e-05 | 166 | 164 | 6 | 063d68f2ffb40770cb4601fa1cb6426ae26f7a37 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.51e-05 | 166 | 164 | 6 | 417cfb207da08fa1a0fd5f2a13c8786628667a8e | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.51e-05 | 166 | 164 | 6 | f28d07715e6b00ca2a0df39273c5f569744be5a8 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.63e-05 | 167 | 164 | 6 | 8ddf9da71a7c4ed53588435db826563a24cee616 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-05 | 168 | 164 | 6 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 169 | 164 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.14e-05 | 171 | 164 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.02e-05 | 177 | 164 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 178 | 164 | 6 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.18e-05 | 178 | 164 | 6 | 982205ba117a4c7b7e9b713689a5b69190f0bca9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.34e-05 | 179 | 164 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.34e-05 | 179 | 164 | 6 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | CV-Severe-4|Severe / Virus stimulation, Condition and Cluster | 5.51e-05 | 180 | 164 | 6 | cf84a01e6a33e5d27ad7be1d9069a0370b5116d1 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.86e-05 | 182 | 164 | 6 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-05 | 183 | 164 | 6 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 6.04e-05 | 183 | 164 | 6 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-05 | 183 | 164 | 6 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 6.04e-05 | 183 | 164 | 6 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 184 | 164 | 6 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 184 | 164 | 6 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 184 | 164 | 6 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.22e-05 | 184 | 164 | 6 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 184 | 164 | 6 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.22e-05 | 184 | 164 | 6 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.22e-05 | 184 | 164 | 6 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 6.41e-05 | 185 | 164 | 6 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.41e-05 | 185 | 164 | 6 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-05 | 185 | 164 | 6 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 186 | 164 | 6 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC2|Liver / Manually curated celltypes from each tissue | 6.61e-05 | 186 | 164 | 6 | 92ef569c8f864d3abaa087cd3ce0366e8f9f50c2 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-05 | 186 | 164 | 6 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 186 | 164 | 6 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-05 | 187 | 164 | 6 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.80e-05 | 187 | 164 | 6 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-05 | 187 | 164 | 6 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-05 | 187 | 164 | 6 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-05 | 187 | 164 | 6 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.80e-05 | 187 | 164 | 6 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.80e-05 | 187 | 164 | 6 | 03de3c2df31bca0dc4e3718bada708d8fe8b69b9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-05 | 116 | 164 | 5 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 188 | 164 | 6 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-05 | 188 | 164 | 6 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.01e-05 | 188 | 164 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-05 | 188 | 164 | 6 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 188 | 164 | 6 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 188 | 164 | 6 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 188 | 164 | 6 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.01e-05 | 188 | 164 | 6 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.01e-05 | 188 | 164 | 6 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.01e-05 | 188 | 164 | 6 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 188 | 164 | 6 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 7.22e-05 | 189 | 164 | 6 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 7.22e-05 | 189 | 164 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 7.22e-05 | 189 | 164 | 6 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.22e-05 | 189 | 164 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 7.43e-05 | 190 | 164 | 6 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.43e-05 | 190 | 164 | 6 | 4b25d49f033bbd326b47cf5602af3f0262cfc367 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 190 | 164 | 6 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-05 | 190 | 164 | 6 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 190 | 164 | 6 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 7.43e-05 | 190 | 164 | 6 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | Control-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 7.65e-05 | 191 | 164 | 6 | 11dfd8f38beb294f42710cfbd355cb089e1023c0 | |
| Disease | heart disease (implicated_via_orthology) | 4.70e-05 | 38 | 155 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | DPYD CATSPERE PNLIPRP1 TFPI2 KIF16B RECQL PFKFB4 DYSF F3 PABPC1 CDH20 MRPS23 APPL1 ATP2A3 PLS3 MED12 VPS13B | 5.30e-05 | 1074 | 155 | 17 | C0006142 |
| Disease | Schizophrenia | CACNA1B DPYD HTR7 GRIK1 HDAC3 PPARGC1A PTPRZ1 SLIT3 TPH2 DLG4 ARHGAP18 CSMD1 C9orf72 ATP2A2 MED12 | 6.84e-05 | 883 | 155 | 15 | C0036341 |
| Disease | dementia, Parkinson disease, disease progression measurement | 8.20e-05 | 3 | 155 | 2 | EFO_0008336, MONDO_0001627, MONDO_0005180 | |
| Disease | Brody myopathy (implicated_via_orthology) | 8.20e-05 | 3 | 155 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | SMOC2 BBS9 LRP1B TMED3 PPARGC1A ZNF665 ZNF83 CSMD1 EFCAB7 PGM2 | 1.34e-04 | 447 | 155 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | migraine (implicated_via_orthology) | 1.63e-04 | 4 | 155 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Cryopyrin-Associated Periodic Syndromes | 1.63e-04 | 4 | 155 | 2 | C2316212 | |
| Disease | Chronic Infantile Neurological, Cutaneous, and Articular Syndrome | 1.63e-04 | 4 | 155 | 2 | C0409818 | |
| Disease | Familial Cold Autoinflammatory Syndrome 1 | 1.63e-04 | 4 | 155 | 2 | C4551895 | |
| Disease | Familial cold urticaria | 1.63e-04 | 4 | 155 | 2 | C0343068 | |
| Disease | Familial cold autoinflammatory syndrome | 1.63e-04 | 4 | 155 | 2 | cv:C0343068 | |
| Disease | Muckle-Wells Syndrome | 2.71e-04 | 5 | 155 | 2 | C0268390 | |
| Disease | Pigmentation Disorders | 2.71e-04 | 5 | 155 | 2 | C0549567 | |
| Disease | Incontinentia Pigmenti Achromians | 2.71e-04 | 5 | 155 | 2 | C0022283 | |
| Disease | post-operative stroke, response to surgery | 2.71e-04 | 5 | 155 | 2 | EFO_0009951, EFO_0009956 | |
| Disease | Schamberg Disease | 2.71e-04 | 5 | 155 | 2 | C0036305 | |
| Disease | interleukin-13 receptor subunit alpha-1 measurement | 2.71e-04 | 5 | 155 | 2 | EFO_0020493 | |
| Disease | pneumonia, COVID-19 | 3.33e-04 | 113 | 155 | 5 | EFO_0003106, MONDO_0100096 | |
| Disease | Congenital Pain Insensitivity | 5.66e-04 | 7 | 155 | 2 | C0002768 | |
| Disease | Autoinflammatory disorder | 8.22e-04 | 35 | 155 | 3 | C3860213 | |
| Disease | sporadic amyotrophic lateral sclerosis | 8.84e-04 | 140 | 155 | 5 | EFO_0001357 | |
| Disease | leptin measurement | 8.90e-04 | 81 | 155 | 4 | EFO_0005000 | |
| Disease | Bipolar Disorder | 9.82e-04 | 477 | 155 | 9 | C0005586 | |
| Disease | Autism Spectrum Disorders | 1.07e-03 | 85 | 155 | 4 | C1510586 | |
| Disease | Takayasu arteritis | 1.13e-03 | 148 | 155 | 5 | EFO_1001857 | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.20e-03 | 10 | 155 | 2 | GO_0097327, GO_0097328 | |
| Disease | Diabetic Cardiomyopathies | 1.46e-03 | 11 | 155 | 2 | C0853897 | |
| Disease | schizophrenia, gastroesophageal reflux disease | 1.46e-03 | 11 | 155 | 2 | EFO_0003948, MONDO_0005090 | |
| Disease | Cognitive impairment | 1.46e-03 | 11 | 155 | 2 | HP_0100543 | |
| Disease | urate measurement, bone density | CHAF1B ASIC2 FSIP2 USP14 PPARGC1A TPH2 MRPS23 TPRG1 SCFD1 USH2A | 1.67e-03 | 619 | 155 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Myeloproliferative disease | 1.75e-03 | 12 | 155 | 2 | C0027022 | |
| Disease | skin melanoma (is_marker_for) | 2.06e-03 | 13 | 155 | 2 | DOID:8923 (is_marker_for) | |
| Disease | Pneumoconiosis | 2.39e-03 | 14 | 155 | 2 | C0032273 | |
| Disease | Bagassosis | 2.39e-03 | 14 | 155 | 2 | C0004681 | |
| Disease | sickle cell anemia (is_marker_for) | 2.39e-03 | 14 | 155 | 2 | DOID:10923 (is_marker_for) | |
| Disease | handedness | 2.40e-03 | 106 | 155 | 4 | EFO_0009902 | |
| Disease | Unipolar Depression | 2.54e-03 | 259 | 155 | 6 | C0041696 | |
| Disease | Autistic Disorder | 2.64e-03 | 261 | 155 | 6 | C0004352 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 2.75e-03 | 15 | 155 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | mannan-binding lectin serine protease 1 measurement | 2.75e-03 | 15 | 155 | 2 | EFO_0008223 | |
| Disease | hepcidin:ferritin ratio | 3.05e-03 | 55 | 155 | 3 | EFO_0007901 | |
| Disease | sleep duration | 3.12e-03 | 362 | 155 | 7 | EFO_0005271 | |
| Disease | facial morphology measurement | 3.33e-03 | 466 | 155 | 8 | EFO_0007841 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.38e-03 | 57 | 155 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | major depressive disorder (is_implicated_in) | 3.54e-03 | 17 | 155 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | respiratory symptom change measurement, response to placebo | 3.54e-03 | 17 | 155 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | Amyotrophic Lateral Sclerosis | 3.55e-03 | 58 | 155 | 3 | C0002736 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 3.97e-03 | 18 | 155 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | cortical thickness change measurement | 3.97e-03 | 18 | 155 | 2 | EFO_0021501 | |
| Disease | carotid artery disease (is_marker_for) | 4.42e-03 | 19 | 155 | 2 | DOID:3407 (is_marker_for) | |
| Disease | Cannabis use, age at onset | 4.42e-03 | 19 | 155 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 4.48e-03 | 63 | 155 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | pulmonary hypertension (is_marker_for) | 4.69e-03 | 64 | 155 | 3 | DOID:6432 (is_marker_for) | |
| Disease | response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement | 4.90e-03 | 20 | 155 | 2 | EFO_0803359, EFO_0803362 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTEVNSGFFYKSAEE | 241 | P40227 | |
| SFCEKNVDYETFKAL | 936 | Q8NHU2 | |
| EISFEAAFGYCTKTL | 636 | Q5SY80 | |
| VQFSCEDNYVLQGSK | 371 | Q96PZ7 | |
| CTLEVDSFGYFVNKA | 931 | P11274 | |
| FGNTSTFCEYTVIKE | 141 | P28332 | |
| KGKEFYVIFDCSHET | 221 | P39086 | |
| DSANKFEENTYCFGR | 496 | Q9H845 | |
| KFSIGAKCNTDTFYF | 311 | Q8NB90 | |
| TDGYCSFVTFEKDEL | 366 | Q13112 | |
| ATVECVKDQFGFINY | 676 | O75534 | |
| NQDFTVIEDYCTGLK | 821 | Q12882 | |
| FCVETVEYKNNTFAV | 51 | Q8IVW1 | |
| QFVEETSYKCDFIQK | 201 | Q9BWV3 | |
| TSKGQKCEFQDAYVL | 231 | P10809 | |
| KSVVSQSVCDYFFEA | 21 | Q9Y2T2 | |
| VQLFKGKFFYCTDES | 1301 | Q00975 | |
| NGFSEKFYLIVIECT | 861 | Q9Y485 | |
| EANCTYFKFFTTGEN | 111 | Q9BXT2 | |
| CSKFVQYETDLTFVG | 581 | Q93084 | |
| LEFNSGSLFCVTKYE | 1086 | Q96BY7 | |
| GSLFCVTKYEGFDDK | 1091 | Q96BY7 | |
| QECGHQDFTTVFTKY | 176 | Q16515 | |
| VVKSAFEGYNACVFA | 86 | Q96L93 | |
| CFAQETFGKQYKQTI | 31 | P51157 | |
| SYIGVCQSKFHFFED | 101 | Q56VL3 | |
| FCYGQLVFTVKEAAA | 221 | P08100 | |
| CSDDVVDYFKRQGFS | 146 | Q96P11 | |
| YDTFSAFGNILSCKV | 116 | P11940 | |
| GTKSCFETKEEVLQY | 76 | Q06481 | |
| DKYFGSVCELDIIFN | 91 | P56377 | |
| YDTFSAFGNILSCKV | 116 | Q13310 | |
| DYFGLTFCDADSQKN | 136 | Q9H4G0 | |
| QEVEDEYKAFCKSFS | 6 | Q58FF3 | |
| CSVHKGFAFVQYDKE | 46 | O60812 | |
| LFRCSNEKGYFAVTE | 1166 | Q13045 | |
| NEKGYFAVTEKCSDF | 1171 | Q13045 | |
| FFTDYGNVAKVERCD | 341 | Q9NZR2 | |
| LEFITNCGKNSFYLD | 1226 | Q16787 | |
| CSVHKGFAFVQYDKE | 46 | B2RXH8 | |
| FFKCLYEGETAQIQS | 266 | Q86Y46 | |
| YIENSNETAFCLGKE | 511 | Q8IWI9 | |
| VEFASEGKYQCVISN | 571 | Q6UXM1 | |
| CSVHKGFAFVQYDKE | 46 | B7ZW38 | |
| CIVDDSFKYNLNGAV | 31 | Q99677 | |
| SVCYIFESNNEGEKI | 601 | Q9UKG1 | |
| EALSEDGQICVYFFK | 1766 | O60318 | |
| NVFVNFKCYLKGETE | 691 | Q5CZC0 | |
| ISNFVYEQFIEKCTS | 5351 | Q5CZC0 | |
| FAKVDLNSNGFICDY | 21 | P13797 | |
| VFKTEEYVVGNFCFL | 81 | Q9NYQ8 | |
| KGEEKTVYNFCSEDT | 441 | P54315 | |
| KASKEQEGEYYCTAF | 561 | P16284 | |
| EQNGYKTFFVESICV | 146 | Q16877 | |
| YGEKFDENDVITCFA | 396 | Q00839 | |
| TTQGFCRYLEKQFSD | 81 | Q96G03 | |
| DYLQSKECDFQTKFA | 226 | Q99836 | |
| KFFTTGQKELYLEAC | 76 | Q0VAA2 | |
| ELFSDFCSKVKNTIY | 991 | Q93074 | |
| GIYFNDDTSKTFACE | 81 | Q9P104 | |
| CSVHKGFAFVQYDKE | 46 | P0DMR1 | |
| KEDCCFTILYGTQFV | 91 | P16885 | |
| FETLKEFYQEVQSCT | 1721 | P23471 | |
| FEENVTGENFFKCIS | 56 | Q6IE36 | |
| EFEQKTSIKDCGVYT | 1001 | Q13219 | |
| YDTFSTFGNILSCKV | 116 | Q4VXU2 | |
| NVFYTSNTCVKVGDF | 201 | Q8IY84 | |
| CEADILKNTSYKGFF | 261 | Q86Y13 | |
| AKKFEASGFCYVNDI | 136 | O15379 | |
| DSYSTLDFGKFNEIC | 1176 | Q6ZV29 | |
| QEYFEKQGVKDFACS | 621 | Q3SYG4 | |
| QYFGCSFDLTKVKDS | 181 | P78552 | |
| DLKFTDFGTYTCVAS | 406 | Q7Z553 | |
| SNETDFELYFCGRKQ | 741 | Q9UBK2 | |
| CFGQRFDYTNSEFKK | 236 | Q7Z449 | |
| DCFVKIYQHEGISSF | 266 | Q9H0C2 | |
| ANFIKYETNLTFVGC | 581 | P16615 | |
| NGFTTTFNVECYDEK | 536 | Q6JEL2 | |
| LCEYQRSGDFKKFEN | 1116 | Q92608 | |
| EEYNFFELRTSGEKC | 426 | A8K855 | |
| RFYEAFVCENAKAGQ | 496 | Q9HBT6 | |
| FGRQDKASTECVKFY | 171 | Q96PZ2 | |
| SELAGLNKQFCYTVE | 406 | Q8IWJ2 | |
| LQYTKTGIFFQAEAC | 51 | Q9Y2G2 | |
| EENQIVSSYASKVCF | 136 | Q9Y2G2 | |
| KAVFYSFEQCSGELS | 381 | Q9NSG2 | |
| FESNSEGEKICYAIN | 596 | Q8NEU8 | |
| LFDYDKTKDCGFLSQ | 436 | P78352 | |
| TTVLKYQKGNCFDFS | 176 | Q8IY82 | |
| QAKYFFKDQVLVSCD | 316 | P48740 | |
| EDPQTISECYQFKFK | 106 | Q86X24 | |
| NFGKDVSTLKYFTIC | 1216 | Q92736 | |
| FCNTFKLYRGKTQEE | 1521 | O75923 | |
| TKVIDFGSSCFEYQK | 351 | O43781 | |
| CEAESSFKYESGLFV | 266 | Q96LT7 | |
| YKESFDVGCNLFAKF | 106 | O15247 | |
| SFQDGVAEKCVDYFQ | 3151 | Q8TE73 | |
| AFKFFDTYCQQEVVG | 461 | Q9BXW9 | |
| TKQEGFLAYFEICSF | 291 | Q12889 | |
| NDLVFFYQVCEGVAK | 736 | O43196 | |
| EFISTFIKKGSCYAL | 81 | O75818 | |
| NLFQKEVDCEKFYSF | 506 | Q96P20 | |
| QKDEKCYEVFSLSQS | 141 | Q9HBJ0 | |
| NFKSTCQRFVEKYTE | 91 | Q9Y3D9 | |
| FFFQVICTTDEGSVK | 4991 | O75445 | |
| KTEVNSGFFYKTAEE | 241 | Q92526 | |
| KDYFTKFGEVVDCTI | 86 | Q99729 | |
| YFKNCTFIDTVFDNT | 531 | Q496J9 | |
| KVTGQLAGDFYFTDC | 206 | Q92581 | |
| EKFTAFCKAQGFTED | 161 | P41222 | |
| NLFAGKFYECINTTD | 1341 | Q15858 | |
| VGVSDFCETKKAYFL | 351 | P30876 | |
| GTFTLGKNYKEEDIC | 506 | Q149N8 | |
| VCKSNEFEKYHLFVG | 1356 | Q9ULL8 | |
| FQKEIEYTCNEGFLL | 2851 | Q4LDE5 | |
| NDDKVCLISQDFGYT | 226 | P34969 | |
| QSIYKTIESKAQECF | 456 | P78536 | |
| FNNIYGFICSLKEEV | 311 | Q8NEL0 | |
| AFKIYDFNTDNFICK | 111 | O75838 | |
| CFAETGQFQKIVLYA | 491 | P53675 | |
| GFQRKCFYFSDDTKN | 81 | Q9UHP7 | |
| TFNKVTGLYEKGCEF | 211 | A8K7I4 | |
| LSFQEVQKNTYDFEC | 86 | Q9H7R5 | |
| SGIIYCFSQKDSEQV | 316 | P46063 | |
| NIIEYNECGTFFSEK | 241 | P17032 | |
| KYVFQCTDGSSFVEE | 1496 | O75094 | |
| EDFNKFCTFVLAYAG | 26 | Q86YI8 | |
| GCAKLFFHTEYEKTN | 186 | P17025 | |
| NECGKFFSQSYDLFK | 316 | Q8TAW3 | |
| TCQVLVKDFTFEGFS | 161 | Q7Z7L7 | |
| TLNSNCEKEGFYKFE | 186 | O75030 | |
| LQQIGFSKYCESFRE | 421 | Q6SZW1 | |
| FSKYCESFREQQVDG | 426 | Q6SZW1 | |
| ADSKYIFCVSGDFVK | 26 | Q8IWA0 | |
| KFVEYCDVNNDKSIS | 391 | Q9H3U7 | |
| CSFGKQVVEKVETEY | 336 | Q99594 | |
| AVNVVDCFFYDGIKA | 681 | O95759 | |
| QSQGTLKFECFYFKE | 81 | Q9NS62 | |
| RAEVKGVYQFCFSNE | 91 | Q9Y3Q3 | |
| ESVQKNEFISEYCGE | 631 | Q92800 | |
| YTSEKFLEICKLSGF | 201 | Q6ZUI0 | |
| EFLGTYNKLTETCFL | 16 | Q9Y5J7 | |
| TQVEYISGKVFFTTC | 41 | Q9BTF0 | |
| QKIYSGEKSYECAEF | 121 | Q52M93 | |
| YGCSELFNATQFIKQ | 621 | Q8WVM8 | |
| VDKGENYCFSVQAVI | 211 | P13726 | |
| LCQELEAKFYEGTFN | 376 | Q8N392 | |
| TCYFFTIEFGLCKQE | 356 | Q8IWU9 | |
| TQQFDDFKKCYGEIL | 856 | Q6PJI9 | |
| IQFTRTQTKDKCYGF | 261 | Q9UJW8 | |
| LTTTQKEIFQCDKYG | 136 | O75346 | |
| KQGSLKQEVESFCYQ | 41 | Q49AG3 | |
| DVFVFSYSCQEGETK | 61 | Q9H6Y2 | |
| ILCFVDYIDFFNTKG | 416 | Q96MP5 | |
| GFYCTKATVTFKLTE | 391 | Q7Z7G8 | |
| SNTVQFLEEYCKFKN | 276 | O95361 | |
| EDFLYSGFQQTADKC | 276 | A6NIX2 | |
| FSYCEETEIEGQKKV | 16 | P0C1S8 | |
| SVDDQCEGSTEKYFF | 101 | P48307 | |
| EFFGISQVDAKYCQI | 2071 | O15050 | |
| IVFSCKNADGVELYN | 81 | E9PB15 | |
| SCFINQEVKYLFTGL | 276 | P54578 | |
| EECGKVFKYFSSFTT | 241 | Q96H40 | |
| IEKGFCQDESIYKTE | 271 | Q92547 | |
| TECGKFFKYNNSFIL | 301 | Q8IVC4 | |
| FTTAQSKVFQCDKYL | 146 | O75437 | |
| FFNKKTLNTESNCEY | 161 | Q9Y473 | |
| YECNFVDSLFTQKEK | 71 | P51522 | |
| FDEISQDTGKYCFGV | 291 | P62495 | |
| QDTGKYCFGVEDTLK | 296 | P62495 | |
| VSKIFFEQGTYQCLE | 406 | P32418 | |
| CGFQDDVAYGKTKIF | 666 | O94832 |